: Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., Britt E.B., Fu X., Wu Y., Li L., Smith J.D., DiDonato J.A., Chen J., Li H., Wu G.D., Lewis J.D., Warrier M., Brown J.M., Krauss R.M., Tang W.H., Bushman F.D., Lusis A.J., Hazen S.L
The combined hormonal activation leads to reduced calorie intake, increased satiety, and enhanced lipid oxidation , yielding potent weight loss and glycemic control [8] [9]
C) Bar graph representing an increase in the number of spines following treatment with vehicle, Nlel -AnglV or Dihexa, ensuring an active phenotype (***=p 0.05
212 This suggests that FBXO31 functions as a tumor suppressor in CCA and modulates the sensitivity to cisplatin by promoting ferroptosis in bile duct cancer cells
Reduced hunger week 1-2